Ignite Creation Date:
2025-12-24 @ 7:40 PM
Ignite Modification Date:
2025-12-25 @ 5:19 PM
Study NCT ID:
NCT01115803
Status:
TERMINATED
Last Update Posted:
2019-02-05
First Post:
2010-04-22
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of LY2584702 With Erlotinib or Everolimus in Participants With Solid Tumors
Sponsor:
Eli Lilly and Company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
12531
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None